Casa bronstein méier resultado

Impact of anti-CD20 monoclonal antibodies on serologic response to

Por um escritor misterioso

Last updated 19 setembro 2024

Impact of anti-CD20 monoclonal antibodies on serologic response to

The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy

Immunogenicity of SARS-CoV-2 vaccines in patients with cancer: Trends in Molecular Medicine

Full article: Effect of FcRn antagonism on protective antibodies and to vaccines in IgG-mediated autoimmune diseases pemphigus and generalised myasthenia gravis

The applications of anti-CD20 antibodies to treat various B cells disorders - ScienceDirect

Humoral and cellular responses after a third dose of BNT162b2 vaccine in patients treated for lymphoid malignancies

Anti-CD20 therapies for multiple sclerosis: current status and future perspectives

The effects of type I and type II anti-CD20 mAb binding to CD20 on

Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy

Overview of therapeutic monoclonal antibodies - UpToDate

Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis

British Journal of Haematology

The future of anti-CD 20 monoclonal antibodies : are we making progress ?

Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients - ScienceDirect

Recomendado para você